Document:

EX-10.12

 Exhibit 10.12 

AMENDED & RESTATED EMPLOYMENT AGREEMENT 

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) dated as of July 7th, 2020 (the “Effective Date”) is made by and between Norvax, LLC (“Norvax”), GoHealth, Inc. (“GoHealth”), GoHealth Holdings, LLC (the
“Partnership” and, together with GoHealth and any of the Affiliates of GoHealth and the Partnership as may employ the Executive from time to time, and any successor(s) thereto, the “Company”), and Brandon Cruz (the
“Executive”). 
 WHEREAS, the Executive previously entered into that certain Employment Agreement dated April 16, 2020
with Norvax (the “Original Agreement”); 
 WHEREAS, the Executive previously entered into that certain Executive Common
Unit and Profits Unit Agreement (the “Profits Unit Agreement”) dated October 3, 2019 with the Partnership and Blizzard Management Feeder, LLC (“Management LLC”) and that certain Amendment No. 1 to the
Profits Unit Agreement with the Partnership and Management LLC dated April 16, 2020 (the “Amendment”); 
 WHEREAS,
GoHealth is contemplating an initial public offering of its common stock (the “IPO”); 
 WHEREAS, in connection with the
IPO, the Company desires to assure itself of the continued services of the Executive by amending and restating the Original Agreement to be by and between the Executive and the Company. 

NOW, THEREFORE, in consideration of the promises and mutual agreements contained herein, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged by both parties, the parties hereby agree as follows: 

1.    Employment. The Company hereby continues to employ the Executive and the Executive
hereby accepts such continued employment upon and subject to the terms and conditions of this Agreement from April 16, 2020 until the fourth (4th) anniversary thereof, unless the
Executive’s employment is earlier terminated in accordance with Section 4 below (such initial period of employment referred to as the “Initial Employment Period”). The Initial Employment Period shall automatically be
extended for successive one year periods (each, an “Extension Employment Period” and, collectively, the “Employment Period”), unless either party hereto gives notice of
non-extension of the Employment Period to the other no later than ninety (90) days prior to the expiration of the then applicable Employment Period; provided, however, that any such notice
provided by the Company to the Executive shall be considered a termination of the Executive’s employment without Cause, effective as of the Executive’s termination of employment on the last day of the Employment Period. The Executive
represents and warrants that Executive is free to enter into this Agreement and is not otherwise prohibited from doing so, or from performing his duties hereunder, by any contract or covenant with any person, company, or other entity. Executive
represents that he is not bound by any agreement which imposes any restriction upon his employment by the Company. The principal place of Executive’s employment with the Company shall be the Company’s office located in Chicago, Illinois;
provided that, the Executive will be expected to conduct reasonable travel for business purposes. A requirement to relocate outside of the Chicago area will be subject to approval by the Executive. 

2.    Position, Duties and Responsibilities. The Company shall employ the Executive during the
Employment Period as its Chief Strategy Officer and Special Advisor to the Executive Team. During the Employment Period: (a) the Executive’s duties and responsibilities shall include providing strategic advice to the Company regarding
growth opportunities, other similar key areas, and such other similar duties commensurate with such position as the Company may from time-to-time assign, subject in each
case to the direction of the Company’s Board of Managers (the “Board”) and duly constituted committees of the Board, and the Executive shall have authority and responsibility with respect to the management and operation of the
Company as authorized by the Board; (b) the Executive shall report to the Board; (c) the Executive shall at all times comply with all policies and procedures of the Company as in effect or as amended from time to time; and (d) the
Executive shall perform the duties assigned to him hereunder faithfully, with the utmost loyalty, to the best of his abilities and in the best interests of the Company. 

3.    Compensation and Benefits. 

a.    Base Salary. During the Employment Period, the Company shall pay to the Executive a base salary at a gross
annualized rate of $325,000 (the “Base Salary”), payable in installments in accordance with the Company’s payroll policy. The Base Salary shall be reviewed annually, and shall be subject to such annual increases, if any, as
determined by the Board in its discretion; provided, however, that Executive’s Base Salary shall be subject to annual percentage increases no less than the annual percentage increase received by the Chief Executive Officer of the
Company (“CEO”). 
  

 b.    Bonus. Subject to Section 4, with respect to each
Company fiscal year that ends during the Employment Period, including for calendar year 2020, the Executive will be eligible to receive a cash bonus with a target amount equal to $175,000 for such fiscal year (the “Annual Bonus”),
which shall be payable based upon the attainment of individual and Company performance goals established by the Board in its sole discretion; provided, however, that the Annual Bonus paid to Executive shall be no less than the annual
bonus paid to the CEO. No Annual Bonus shall be payable with respect to any fiscal year unless the executive remains continuously employed with the Company during the period beginning on the Effective Date and ending on the applicable Annual Bonus
payment date. 
 c.    Employee Benefits. During the Employment Period, the Executive shall be eligible to
participate in such employee benefit plans, and to receive such other fringe benefits, as the Company may in its discretion make available to its other executives, subject to all present and future terms and conditions of such benefit plans and
other fringe benefits; provided, however, that Executive will be eligible to participate in the same employee benefit plans and receive such other fringe benefits as the CEO. 

d.    Expense Reimbursement. During the Employment Period, the Company shall reimburse the Executive for all
reasonable and necessary business expenses (as determined by the Company) incurred by the Executive in connection with the Executive’s duties hereunder in accordance with the Company’s business expense reimbursement policies, as in effect
or amended from time to time. Notwithstanding the foregoing, nothing in this Agreement will affect the Executive’s Airplane Reimbursement Arrangement (as defined under the Profits Unit Agreement), which shall remain in effect to the extent
provided by the terms of the Profits Unit Agreement. 
 e.    Withholding; Compliance with IRS Code
Section 409A. 
 i.    All amounts and benefits payable under this Agreement shall be reduced by
any and all required or authorized withholding and deductions. 
 ii.    This Agreement shall be interpreted and
construed in a manner that avoids the imposition of taxes and other penalties under Section 409A of the Internal Revenue Code of 1986, as amended (such code referred to as the “Code,” and such taxes and other penalties referred to
collectively as “409A Penalties”). In the event that the terms of this Agreement would subject the Executive to 409A Penalties, the Company and the Executive shall cooperate diligently to amend the terms of this Agreement to avoid such
409A Penalties, to the extent possible. All references in this Agreement to the Executive’s termination of employment and to the end of the Employment Period shall mean a separation from service within the meaning of Section 409A of the
Code. Each payment under this Agreement as a result of the separation of the Executive’s service shall be considered a separate payment for purposes of Section 409A of the Code. Any reimbursement (including any advancement) payable to the
Executive pursuant to this Agreement shall be conditioned on compliance with the Company’s business expense reimbursement policies, as in effect or amended from time to time. Any amount of expenses eligible for reimbursement or in-kind benefit provided during a calendar year shall not affect the amount of expenses eligible for reimbursement or in-kind benefit to be provided during any other calendar
year. The right to reimbursement or to an in-kind benefit pursuant to this Agreement shall not be subject to liquidation or exchange for any other benefit. Notwithstanding any other provision in this
Agreement, if on the date of the Executive’s separation from service (as defined in Section 409A of the Code) (i) the Company is a publicly traded corporation and (ii) the Executive is a “specified employee,” as defined
in Section 409A of the Code, then to the extent any amount payable under this Agreement upon the Executive’s separation from service constitutes the payment of nonqualified deferred compensation, within the meaning of Section 409A of
the Code, that under the terms of this Agreement would be payable prior to the six (6) month anniversary of the Executive’s separation from service, such payment shall be delayed until the earlier to occur of (x) the first day of the
seventh month following the Executive’s separation from service or (y) the date of the Executive’s death. Notwithstanding any of the foregoing provisions of this Section 3(h)(ii), under no circumstances shall the Company be
responsible for any taxes, penalties, interest or other losses or expenses incurred by the Executive due to any failure to comply with Section 409A of the Code.     

f.    D&O Insurance. During the Employment Period, the Company shall cause the Executive to be listed as a
named insured, or otherwise covered as an insured person, under such generally applicable directors and officers insurance coverage as it may elect to maintain from time to time. The Company shall use commercially reasonable efforts to cause the
Executive to continue to be listed as a named insured, or otherwise covered as an insured person, under such generally applicable directors and officers insurance coverage as it may elect to maintain from time to time for a reasonable period (which
shall in no event exceed six (6) years) after the Employment Period, provided that such coverage for the Executive is reasonably available from the Company’s then-existing insurance compan(ies) and is reasonably priced, in each case as
determined by the Company in its good faith discretion. Nothing herein prohibits the Company from suspending, amending or discontinuing its directors and officers insurance or from changing insurance carriers at any time for any or no reason with or
without notice, as long as any such actions are applicable to Company executives generally. 
  

 4.    Termination. 

a.    Notwithstanding anything to the contrary in this Agreement or any other agreement, the Executive’s employment
and the Employment Period may only be terminated as provided in this Section 4: 
 i.    Subject to the
remainder of this Section 4, the Company may only terminate the Executive’s employment and the Employment Period if the Executive engages in conduct during the Employment Period that constitutes Cause (as defined herein) and only after
written notice to the Executive (and the Company may not terminate the Executive’s employment and the Employment Period without Cause). 

ii.    Subject to the remainder of this Section 4, the Executive may for any or no reason terminate his employment
and the Employment Period upon sixty (60) days written notice to the Company. 
 iii.    Subject to the remainder
of this Section 4, the Company may terminate the Executive’s employment and the Employment Period due to Disability (as defined herein) effective upon sixty (60) days written notice to the Executive. 

iv.    Subject to the remainder of this Section 4, the Executive’s employment and the Employment Period shall
automatically terminate upon the Executive’s death. 
 b.    In the event of termination, the Executive shall
cooperate fully with the Company in transitioning the Executive’s duties, responsibilities and client relationships as directed by the Company, and in providing input and assistance on matters that relate to the Executive’s employment
(provided that the Company will reimburse the Executive for the reasonable out-of-pocket costs of any such cooperation after his employment terminates). 

c.    Upon a termination of the Executive’s employment for any reason, (i) the Executive (or the
Executive’s estate) shall be entitled to receive: (A) any portion of the Executive’s Base Salary through the Date of Termination (as defined herein) not theretofore paid, (B) any expenses owed to the Executive under
Section 3(d), (C) any accrued but unused vacation pay owed to the Executive pursuant to applicable law, and (D) any amount arising from the Executive’s participation in, or benefits under, any employee benefit plans, programs or
arrangements under Section 3(c), which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements, and (ii) if the Executive timely elects to receive continued coverage
under the Company’s group health care plan pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company will continue to pay the employer portion of applicable premium payments for
the Executive’s and his eligible dependents’ continued COBRA coverage under such plan (as in effect or amended from time to time) (the “COBRA Subsidy”) until the earlier of: (I) twelve (12) months following the Date
of Termination, or (II) the date upon which the Executive obtains or becomes eligible for other health care coverage from a new employer or otherwise (such period referred to as the “COBRA Subsidy Period”). The Executive shall
promptly inform the Company in writing when he obtains or becomes eligible for any such other health care coverage. The Executive shall be responsible for paying a share of such COBRA premiums during the COBRA Subsidy Period at active employee rates
as in effect from time to time, and shall be responsible for the full unsubsidized costs of such COBRA coverage thereafter. The Executive will be deemed to receive income attributable to the COBRA Subsidy and shall be responsible for any and all
applicable tax liability arising from such benefit. Notwithstanding the foregoing, the COBRA Subsidy will be subject to the Executive’s execution and non-revocation of a waiver and release of claims
agreement in the Company’s customary form (a “Release”) and will not be provided in the event of Executive’s termination of employment for Cause. 

d.    In the event of the Executive’s termination of employment by the Executive for Good Reason or as a result of a non-extension of the Employment Period by the Company, in addition to the payments and benefits described in Section 4(c) above, the Company shall, subject to Section 5 and subject to Executive’s
execution and non-revocation of a Release: 
 i.    Continue to pay
Executive’s Base Salary during the period beginning on the Date of Termination and ending on the two (2) year anniversary of the Date of Termination in accordance with the Company’s regular payroll practice as of the Date of
Termination; and 
 ii.    Pay (A) the Annual Bonus for any completed fiscal year as of the Date of Termination
that has not yet been paid as of the Date of Termination, if any, and (B) the product of (I) two (2), multiplied by (II) a pro-rated portion of the Annual Bonus for the year in which the
Date of Termination occurs, with such proration being based on the number of full months for which the Executive was employed during such year prior to such Date of Termination. The bonuses described in this Section 4(d)(ii) shall be payable,
to the extent earned, on, or at such date as is determined by the Board within 120 days following, the last day of the fiscal year with respect to which it relates. 

 e.    Notwithstanding any other provision of this Agreement, no payment
shall be made or benefit provided pursuant to Section 4(d) following the date Executive first violates the Restrictive Covenant Agreement and, in the event of such a violation, Executive shall repay to the Company any benefit provided pursuant
to Section 4(d) within ninety (90) days of such violation. 
 f.    The provisions of this Section 4
shall supersede in their entirety any severance payment or benefit obligations to the Executive pursuant to the provisions in any severance plan, policy, program or other arrangement maintained by the Company. 

5.    Restrictive Covenant Agreement. Executive acknowledges that Executive, concurrently with the
execution of the Original Agreement, entered into an agreement with the Company containing confidentiality, non-solicitation, non-competition, intellectual property
assignment, and other protective covenants (the “Restrictive Covenant Agreement”) and that the Executive shall be bound by the terms and conditions of the Restrictive Covenant Agreement during and following the Employment Period.

 6.    Definitions. As used in this Agreement: 

a.    “Affiliate” shall have the meaning given in the Profits Unit Plan. 

b.    “Cause” means (i) (A) the willful failure or refusal of the Executive to perform material
responsibilities set forth herein (including Executive’s failure to devote time and attention to his duties hereunder or failure to regularly attend Board or office meetings); (B) the Executive’s willful failure to carry out, or comply
with, in any material respect any lawful directive of the Board; (C) dishonesty by the Executive to the Board with respect to any material matter; (D) misappropriation of funds or property of the Company or any of its Subsidiaries or
Affiliates by the Executive other than the occasional, customary and de minimis use of Company property for personal purposes; or (E) a breach by the Executive of this Agreement or other agreement with the Company (including, without
limitation, the Restrictive Covenants Agreement); provided, in the case of each of clause (i)(A)-(E), if the Board (excluding any Manager as to whom Cause is alleged to have occurred) determines reasonably and in good faith that such act can
reasonably be cured, that the Company has provided 30 days’ prior written notice to the Executive of such conduct and the Executive has failed to cure such conduct within such 30 day period in the manner identified by the Board; (ii) the
arrest or charging of the Executive for (A) any felony or (B) a misdemeanor involving moral turpitude, deceit, dishonesty or fraud, and which is materially detrimental to the Company and its Subsidiaries and Affiliates (including material
reputational harm); or (iii) the Executive’s engagement in on-the-job conduct that consists either of gross misconduct or a material violation of the Company
or any of its Subsidiaries’ or Affiliates’ written code of ethics or Company policies, and which is materially detrimental to the Company and its Subsidiaries and Affiliates (including material reputational harm). 

c.    “Date of Termination” shall mean (i) if the Executive’s employment is terminated due to
the Executive’s death, the date of the Executive’s death; (ii) if the Executive’s employment is terminated due to the Executive’s Disability, the date determined pursuant to Section 4(a)(iii); (iii) if the
Executive’s employment is terminated pursuant to Section 4(a)(i), the date notice of such termination for Cause is delivered to the Executive (or the date of the expiration of any applicable cure period, if later); or (iv) if the
Executive’s employment is terminated pursuant to Section 4(a)(ii), at the end of such sixty (60) day notice period (or any such earlier date agreed to in writing by the Company). 

d.    “Disability” shall have the meaning given in the Profits Unit Plan. 

e.    “Good Reason” means the continued occurrence of any of the following without the Executive’s
consent, subject to the notice and cure conditions set forth below: (A) a material adverse change in the Executive’s title, reporting relationship, or authority; (B) a material adverse change in the Executive’s duties and
responsibilities as of the Effective Date; (C) a reduction in the Executive’s Base Salary not otherwise made on a substantially similar basis for senior Company executives generally; (D) a material breach of any other provision of
this Agreement; (E) the requirement that the Executive relocate on a permanent basis (except for required business travel) to a location more than 30 miles from the Chicago, Illinois metropolitan area, or (F) the failure of any acquirer
who purchases all or substantially all of the assets or business of the Company to assume and agree to be bound by this Agreement. Executive’s employment with the Company may be terminated for Good Reason only if (1) Executive provides
written notice to the Company of the occurrence of the Good Reason event (as described above) within 30 days after the Executive knows or reasonably should have known of the circumstances constituting Good Reason, (2) the Company fails to cure
the circumstances constituting “Good Reason” within 30 days after such notice, and (3) Executive resigns within 30 days after the expiration of such 30-day cure period. For the avoidance of
doubt, an initial public offering of common stock of the Company or any parent (direct or indirect) or other Affiliate of the Company shall not constitute Good Reason for purposes of this Agreement. 

f.    “Profits Unit Plan” shall mean the Blizzard Parent, LLC Profits Unit Plan. 

g.    “Subsidiary(ies)” shall have the meaning given in the Profits Unit Plan. 

 

 7.    Notices.    Any
notice, request, or other communication required or permitted to be given hereunder shall be made to the following addresses or to any other address designated by either of the parties hereto by notice similarly given: (a) if to the
Company, to Brad Burd, ####@gohealth.com, 214 W. Huron St., Chicago, Illinois 60654; and (b) if to the Executive, to Brandon Cruz, ####@gmail.com, ####. 

All such notices, requests, or other communications shall be sufficient if made in writing either (i) by personal delivery to the party
entitled thereto, (ii) by facsimile with confirmation of receipt, (iii) by certified mail, return receipt requested, (iv) by express courier service, and shall be effective upon personal delivery, upon confirmation of receipt of
facsimile transmission, upon the fourth calendar day after mailing by certified mail, or upon the second calendar day after sending by express courier service, or (v) by email with confirmation of receipt, and shall be effective upon receipt by
the sending party of such confirmation of receipt. 
 8.    Assignment. This Agreement is
enforceable by the Company and its Subsidiaries and Affiliates and may be assigned or transferred by the Company to, and shall inure to the benefit of, any Subsidiary or Affiliate of the Company or any person which at any time, whether by merger,
purchase, or otherwise, acquires all or substantially all of the assets, stock or business of the Company or of any discrete portion thereof. Any such assignment or transfer shall not constitute a termination of the Executive’s employment for
purposes of this Agreement. The Executive may not assign any of his rights or obligations under this Agreement. 

9.    No Interference. Nothing in this Agreement prohibits the Executive from filing a charge
with, or reporting possible violations of federal law or regulation to any governmental agency or regulatory entity, including but not limited to the U.S. Equal Opportunity Commission, the Department of Justice, the Securities and Exchange
Commission, the Congress, and any agency Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. The Executive does not need the prior authorization of the Company to make
any such reports or disclosures and is not required to notify the Company that he/she has made such reports or disclosures. 

10.    Amendment and Waiver.    This Agreement may not be amended orally
and may only be amended by a written agreement signed by both parties (subject to Section 15 herein). A waiver by either party hereto of any of its rights or remedies under this Agreement on any occasion shall not be a bar to the exercise of
the same right or remedy on any subsequent occasion or of any other right or remedy at any time. 

11.    Governing Law; Jurisdiction; Venue.    This Agreement shall be
governed by the internal laws of the state of Illinois, without regard to its conflict of laws rules. The parties hereby irrevocably consent to, and agree not to object or assert any defense or challenge to, the exclusive jurisdiction and exclusive
venue of the state and federal courts located in Chicago, Illinois, and agree that any claim which may be brought in a court of law or equity shall be brought exclusively in any such Chicago, Illinois court. 

12.    Headings.    The Section headings used herein are for convenience
of reference only and are not to be considered in construction of the provisions of this Agreement. 

13.    Entire Agreement; Survival; Payments to Beneficiaries. Except for the Profits Unit
Agreement, the Amendment, and the Restrictive Covenant Agreement, this Agreement contains the entire agreement between the parties with respect to the subject matter contained herein and supersedes all prior or contemporaneous negotiations,
understandings or agreements between the parties, whether written or oral, with respect to such subject matter. Sections 4 through 17 herein shall survive and continue in full force and effect in accordance with their respective terms,
notwithstanding any termination of the Employment Period or the Executive’s employment. If the Executive dies before receiving any amounts to which the Executive is entitled under this Agreement, such amounts shall be paid in accordance with
the terms of this Agreement to the beneficiary designated in writing by the Executive, or if none is so designated, to the Executive’s estate. 

14.    Severability.    Whenever possible, each provision of this Agreement
will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective only to the extent of such
prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

15.    Counterparts. This Agreement may be executed in two counterparts, each of which shall
be deemed an original, and both of which together shall constitute one and the same instrument. 

16.    Condition Precedent to Effectiveness. This Agreement and the Executive’s
employment hereunder will not be effective unless and until the Amendment and the Restrictive Covenant Agreement are validly executed and of full force and effect, and this Agreement shall be null and void and shall be of no force and effect in the
event that either the Amendment or the Restrictive Covenant Agreement is not executed and of full force and effect for any reason. 

 THE PARTIES ACKNOWLEDGE BY SIGNING BELOW THAT THEY HAVE READ AND UNDERSTAND THE ABOVE AND INTEND TO BE
BOUND THEREBY: 
  

							
	Brandon Cruz	 		 	Norvax, LLC
				
	/s/ Brandon Cruz	 		 	By:	 	 /s/ Jeremy W. Gelber

	Date: July 7, 2020	 		 	Name:	 	Jeremy W. Gelber
		 		 	Position:	 	Authorized Signatory
		 		 	Date:	 	July 7, 2020

  

							
		 		 	GoHealth, Inc.
				
		 		 	By:	 	 /s/ Clinton P. Jones

		 		 	Name:	 	Clinton P. Jones
		 		 	Position:	 	Chief Executive Officer
		 		 	Date:	 	July 7, 2020

  

							
		 		 	GoHealth Holdings, LLC
				
		 		 	By:	 	 /s/ Clinton P. Jones

		 		 	Name:	 	Clinton P. Jones
		 		 	Position:	 	Chief Executive Officer
		 		 	Date:	 	July 7, 2020EX-10.13

 Exhibit 10.13 

EXECUTION VERSION 

Employment Agreement 

This Employment Agreement (the “Agreement”), entered into as of July 7, 2020, is made by and between Clint Jones (the
“Executive”), GoHealth, Inc., a Delaware corporation (“GoHealth”), and GoHealth Holdings, LLC, a Delaware limited liability company (the “Partnership” and, together with GoHealth and any of
the Affiliates of GoHealth and the Partnership as may employ the Executive from time to time, and any successor(s) thereto, the “Company”). 

RECITALS 
 WHEREAS,
the Executive is currently employed by Norvax, LLC, a subsidiary of the Company (“Norvax”), as the Chief Executive Officer of Norvax; 

WHEREAS, GoHealth is contemplating an initial public offering of its common stock (the “IPO”); 

WHEREAS, in connection with the IPO, the Company desires to assure itself of the continued services of the Executive by engaging the
Executive to perform services under the terms hereof; 
 WHEREAS, the Executive desires to provide services to the Company on the
terms herein provided; and 
 WHEREAS, the Company and the Executive desire to have the Agreement become effective as of the date of
the consummation of the IPO (the “Effective Date”). 
 AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants
and agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree, effective as of the Effective Date, as follows: 

1. Certain Definitions 

(a) “Affiliate” shall mean, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or
under common control with, such Person where “control” shall have the meaning given such term under Rule 405 of the Securities Act of 1933, as amended from time to time. 

(b) “Agreement” shall have the meaning set forth in the preamble hereto. 

(c) “Annual Base Salary” shall have the meaning set forth in Section 3(a). 

(d) “Annual Bonus” shall have the meaning set forth in Section 3(b). 

 

  
 1 

 EXECUTION VERSION 

 

 (e) “Board” shall mean the Board of Directors of GoHealth, Inc., a Delaware
corporation. 
 (f) The Company shall have “Cause” to terminate the Executive’s employment hereunder upon: (i)(A) the
willful failure or refusal of the Executive to perform material responsibilities set forth herein (including Executive’s failure to devote time and attention to his duties hereunder or failure to regularly attend Board or office meetings); (B)
the Executive’s willful failure to carry out, or comply with, in any material respect any lawful directive of the Board; (C) dishonesty by the Executive to the Board with respect to any material matter; (D) misappropriation of funds
or property of the Company or any of its Affiliates by the Executive other than the occasional, customary and de minimis use of Company property for personal purposes; or (E) a breach by the Executive of this Agreement or other agreement
with the Company (including, without limitation, the Restrictive Covenants Agreement); provided, in the case of each of clause (i)(A)-(E), if the Board (excluding any Board member as to whom Cause is alleged to have occurred) determines
reasonably and in good faith that such act can reasonably be cured, that the Company has provided 30 days’ prior written notice to the Executive of such conduct and the Executive has failed to cure such conduct within such 30 day period in the
manner identified by the Board; (ii) the arrest or charging of the Executive for (A) any felony or (B) a misdemeanor involving moral turpitude, deceit, dishonesty or fraud, and which is materially detrimental to the Company and its
Affiliates (including material reputational harm); or (iii) the Executive’s engagement in on-the-job conduct that consists either of gross misconduct or a
material violation of the Company or any of its Affiliates’ written code of ethics or Company policies, and which is materially detrimental to the Company and its Affiliates (including material reputational harm). 

(g) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(h) “Company” shall have the meaning set forth in the preamble hereto. 

(i) “Date of Termination” shall mean (i) if the Executive’s employment is terminated due to the Executive’s
death, the date of the Executive’s death; (ii) if the Executive’s employment is terminated due to the Executive’s Disability, the date determined pursuant to Section 4(a)(ii); or (iii) if the Executive’s employment
is terminated pursuant to Section 4(a) (iii)-(vi) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 4(b), whichever is earlier. 

(j) “Disability” shall mean the Executive’s inability to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment that can be expected to result in death or that can be expected to last for a continuous period of not less than twelve (12) months. 

(k) “Effective Date” shall have the meaning set forth in the recitals hereto. 

(l) “Executive” shall have the meaning set forth in the preamble hereto. 

(m) “Extension Term” shall have the meaning set forth in Section 2(b). 

  
 2 

 EXECUTION VERSION 

 

 (n) The Executive shall have “Good Reason” to terminate the Executive’s
employment hereunder after the occurrence of one or more of the following conditions without the Executive’s consent: (A) a material adverse change in the Executive’s authority or duties and responsibilities as of the Effective Date
(provided that, for the avoidance of doubt, any change in the Executive’s authority or duties and responsibilities made in connection with the IPO shall not be considered a material adverse change for purposes hereof); (B) a material reduction
in the Executive’s Annual Base Salary or Annual Bonus opportunity, in either case not otherwise made on a substantially similar basis for senior Company executives generally; or (C) the requirement that the Executive relocate on a
permanent basis (except for required business travel) to a location more than 50 miles from the Chicago, Illinois metropolitan area. Executive’s employment with the Company may be terminated for Good Reason only if (1) Executive provides
written notice to the Company of the occurrence of the Good Reason event (as described above) within 30 days after the Executive knows or reasonably should have known of the circumstances constituting Good Reason, (2) the Company fails to cure
the circumstances constituting “Good Reason” within 30 days after such notice, and (3) Executive resigns within 30 days after the expiration of such 30-day cure period. For the avoidance of
doubt, an initial public offering of common stock of the Company or any parent (direct or indirect) or other Affiliate of the Company shall not constitute Good Reason for purposes of this Agreement. 

(o) “Initial Term” shall have the meaning set forth in Section 2(b). 

(p) “IPO” shall have the meaning set forth in the recitals hereto. 

(q) “Notice of Termination” shall have the meaning set forth in Section 4(b). 

(r) “Person” shall mean any individual, natural person, corporation (including any
non-profit corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, company (including any company limited by shares, limited liability company or
joint stock company), incorporated or unincorporated association, governmental authority, firm, society or other enterprise, organization or other entity of any nature. 

(s) “Release” shall have the meaning set forth in Section 5(b). 

(t) “Release Expiration Date” shall have the meaning set forth in Section 21(c). 

(u) “Restrictive Covenant Agreement” shall have the meaning set forth in Section 6. 

(v) “Section 409A” shall mean Section 409A of the Code and the Department of Treasury regulations and
other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective Date. 

(w) “Severance Period” shall have the meaning set forth in Section 5(b). 

(x) “Term” shall have the meaning set forth in Section 2(b). 

(y) “Transitional Role” shall have the meaning set forth in Section 2(c). 

  
 3 

 EXECUTION VERSION 

 

 2. Employment 

(a) In General. Effective as of the Effective Date, the Company shall employ the Executive under this Agreement and the Executive shall
remain in the employ of the Company under this Agreement, for the period set forth in Section 2(b), in the position set forth in Section 2(c), and upon the other terms and conditions herein
provided. 
 (b) Term of Employment. The initial term of employment under this Agreement (the “Initial Term”)
shall be for the period beginning on the Effective Date and ending on the third anniversary thereof, unless earlier terminated as provided in Section 4. The Initial Term shall automatically be extended for successive one
year periods (each, an “Extension Term” and, collectively with the Initial Term, the “Term”), unless either party hereto gives notice of non-extension of the Term to the other
no later than ninety (90) days prior to the expiration of the then-applicable Term. For the avoidance of doubt, notice by the Executive of non-extension of the Term, without stated Good Reason and
compliance with the notice, cure, and resignation requirements of the definition thereof, shall not constitute a resignation for Good Reason under Section 4(a)(v). For the further avoidance of doubt, notice by the Company
of non-extension of the Term, without stated Cause and compliance with the notice and cure requirements of the definition thereof and subject to Section 4(b), shall constitute a
termination without Cause under Section 4(a)(iv). 
 (c) Position and Duties. During the Initial Term, the
Executive: (i) shall serve as Chief Executive Officer of the Company, with responsibilities, duties and authority customary for such position, subject to direction by the Board; (ii) shall report directly to the Board; (iii) shall
devote substantially all the Executive’s working time and efforts to the business and affairs of the Company and its Affiliates; (iv) agrees to observe and comply with the Company’s rules and policies as adopted by the Company from
time to time. In addition, as of the Effective Date, the Company shall cause the Executive to be appointed to the Board and as Co-Chairperson of the Board, and, during the Term, the Board shall propose the
Executive for re-election to the Board and, as long as Executive serves as Chief Executive Officer of the Company, as Chairperson of the Board. The parties acknowledge and agree that Executive’s duties,
responsibilities and authority may include services for one or more Affiliates of the Company. After the Initial Term, as mutually agreed by the parties at the time, Executive’s role may change to a role other than Chief Executive Officer (the
“Transitional Role”) for the remainder of the Term. For the avoidance of doubt, in the event that the Executive’s role changes to a Transitional Role: (A) unless amended by mutual agreement of the parties hereto, the terms
and conditions of this Agreement will remain in effect for the remainder of the Term, except as set forth in Section 3(a) and (b) and a change in title, as mutually agreed by the parties at the time of such
transition; (B) Executive shall continue to be eligible to participate in the Company’s group health plan, employee benefit plans, programs and arrangements; and (C) such Transitional Role shall not begin the Severance Period. 

  
 4 

 EXECUTION VERSION 

 

 3. Compensation and Related Matters 

(a) Annual Base Salary. During the period of the Term during which the Executive’s position is Chief Executive Officer of the
Company, the Executive shall receive a base salary at a rate of $325,000 per annum, which shall be paid in accordance with the customary payroll practices of the Company, subject to review by the Board in its sole discretion (the “Annual
Base Salary”). Should Executive’s position change to a Transitional Role, the parties may reach a mutually agreeable change in the Annual Base Salary; provided, however, that any change in Executive’s Annual
Base Salary resulting from Executive’s position changing to a Transitional Role shall not be considered a material reduction in the Executive’s Annual Base Salary for purposes of the definition of “Good Reason” under
Section 1(n). 
 (b) Annual Bonus. With respect to each Company fiscal year during the Term, the Executive
will be eligible to receive a cash bonus (the “Annual Bonus”), which shall be payable based upon the attainment of individual and Company performance goals established by the Board in its sole discretion. Each such Annual Bonus
shall be payable, to the extent earned, on, or at such date as is determined by the Board within 120 days following, the last day of the fiscal year with respect to which it relates. Notwithstanding any other provision of this
Section 3(b) and subject to Section 5(b), no bonus shall be payable with respect to any fiscal year unless the Executive remains continuously employed with the Company during the period beginning
on the Effective Date and ending on the applicable bonus payment date. Should Executive’s position change to a Transitional Role, the parties may reach a mutually agreeable change in the structure of the Annual Bonus; provided,
however, that any change in Executive’s Annual Bonus resulting from Executive’s position changing to a Transitional Role shall not be considered a material reduction in the Executive’s Annual Bonus opportunity for purposes of
the definition of “Good Reason” under Section 1(n). 
 (c) Benefits. During the Term, the
Executive shall be eligible to participate in employee benefit plans, programs and arrangements of the Company in accordance with their terms, as in effect from time to time, and as are generally provided by the Company to its senior executive
officers. 
 (d) Business Expenses. During the Term, the Company shall reimburse the Executive for all reasonable, documented, out-of-pocket travel and other business expenses incurred by the Executive in the performance of the Executive’s duties to the Company in accordance with the
Company’s applicable expense reimbursement policies and procedures. Notwithstanding the foregoing, nothing in this Agreement will affect the Executive’s Airplane Reimbursement Arrangement (as defined in the Executive Common Unit and
Profits Unit Agreement by and between the Partnership, Blizzard Management Feeder, LLC, and the Executive dated October 3, 2019 (the “Profits Unit Agreement”)), which shall remain in effect to the extent provided by the terms
of the Profits Unit Agreement. 
 (e) Indemnification. During the Term and for so long thereafter as liability exists with regard to
the Executive’s activities during the Term on behalf of the Company, the Company shall defend and indemnify the Executive (other than in connection with the Executive’s gross negligence or willful misconduct) in accordance with the
Company’s customary indemnification policies and procedures which are applicable to the Company’s officers and directors. 

  
 5 

 EXECUTION VERSION 

 

 4. Termination. The Executive’s employment hereunder may be terminated by
the Company or the Executive, as applicable, without any breach of this Agreement only under the following circumstances: 
 (a)
Circumstances 
 (i) Death. The Executive’s employment hereunder shall terminate upon the Executive’s
death. 
 (ii) Disability. If the Executive incurs a Disability, the Company may give the Executive written notice of
its intention to terminate the Executive’s employment. In that event, the Executive’s employment with the Company shall terminate, effective on the later of the thirtieth (30th) day
after receipt of such notice by the Executive or the date specified in such notice; provided that within the thirty (30) day period following receipt of such notice, the Executive shall not have returned to full-time performance of the
Executive’s duties hereunder. 
 (iii) Termination for Cause. The Company may terminate the Executive’s
employment for Cause. 
 (iv) Termination without Cause. The Company may terminate the Executive’s employment
without Cause. 
 (v) Resignation for Good Reason. The Executive may resign from the Executive’s employment for
Good Reason. 
 (vi) Resignation without Good Reason. The Executive may resign from the Executive’s employment
without Good Reason. 
 (b) Notice of Termination. Any termination of the Executive’s employment by the Company or by the
Executive under this Section 4 (other than a termination pursuant to Section 4(a)(i) above) shall be communicated by a written notice to the other party hereto (a “Notice of
Termination”): (i) indicating the specific termination provision in this Agreement relied upon, and (ii) specifying a Date of Termination which, if submitted by the Executive, shall be at least thirty (30) days following the date
of such notice; provided, however, that a Notice of Termination delivered by the Company pursuant to Section 4(a)(ii) shall not be required to specify a Date of Termination, in which case the Date of
Termination shall be determined pursuant to Section 4(a)(ii); and provided, further, that in the event that the Executive delivers a Notice of Termination to the Company, the Company may, in its sole
discretion, accelerate the Date of Termination to any date that occurs following the date of Company’s receipt of such Notice of Termination (even if such date is prior to the date specified in such Notice of Termination). A Notice of
Termination submitted by the Company (other than a Notice of Termination under Section 4(a)(ii)) may provide for a Date of Termination on the date the Executive receives the Notice of Termination, or any date thereafter
elected by the Company in its sole discretion. The failure by the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause shall not preclude the Company from asserting such fact or
circumstance in enforcing the Company’s rights hereunder in connection with such Termination for Cause. Notwithstanding the foregoing, a termination pursuant to Section 4(a)(iii) shall be deemed to occur if following
Executive’s termination of employment for any reason the Company determines that circumstances existing prior to such termination would have entitled the Company to terminate Executive’s employment pursuant to
Section 4(a)(iii) (disregarding any applicable cure period). 

  
 6 

 EXECUTION VERSION 

 

 5. Company Obligations Upon Termination of Employment 

(a) In General. Upon a termination of the Executive’s employment for any reason, the Executive (or the Executive’s estate)
shall be entitled to receive: (i) any portion of the Executive’s Annual Base Salary through the Date of Termination not theretofore paid, (ii) any expenses owed to the Executive under Section 3(d), (iii) any
accrued but unused vacation pay owed to the Executive in accordance with applicable law, and (iv) any amount arising from the Executive’s participation in, or benefits under, any employee benefit plans, programs or arrangements under
Section 3(c), which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements. Except as otherwise set forth in Section 5(b)
below, the payments and benefits described in this Section 5(a) shall be the only payments and benefits payable in the event of the Executive’s termination of employment for any reason. 

(b) Severance Payments. In the event of the Executive’s termination of employment by the Company without Cause pursuant to
Section 4(a)(iv) or by the Executive for Good Reason pursuant to Section 4(a)(v), in addition to the payments and benefits described in Section 5(a) above, the Company
shall, subject to Section 21 and Section 5(c) and subject to Executive’s execution and non-revocation of a waiver and release of claims agreement in the
Company’s customary form (a “Release”), as of the Release Expiration Date, in accordance with Section 21(c): 

(i) Continue to pay Executive’s Annual Base Salary during the period beginning on the Date of Termination and ending on
the two (2) year anniversary of the Date of Termination (the “Severance Period”) in accordance with the Company’s regular payroll practice as of the Date of Termination; and 

(ii) Pay (A) the Annual Bonus for any completed fiscal year as of the Date of Termination that has not yet been paid as of
the Date of Termination, if any, and (B) the product of (I) two (2), multiplied by (II) a pro-rated portion of the Annual Bonus for the year in which the Date of Termination occurs, with
such proration being based on the number of full months for which the Executive was employed during such year prior to such Date of Termination. The bonuses described in this Section 5(b)(ii) shall be payable, to the extent
earned, on, or at such date as is determined by the Board within 120 days following, the last day of the fiscal year with respect to which it relates, as set forth in Section 3(b). 

(iii) During the Severance Period, if the Executive elects to continue coverage under the Company’s group health plan in
accordance with the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), continue coverage for the Executive and any eligible dependents under the Company group health benefit plans in which the Executive
and any dependents were entitled to participate immediately prior to the Date of Termination. In the event Executive elects to continue with COBRA coverage, provided, that Employee timely submits to the Company evidence of Executive’s payments
made to the COBRA administrator, the Company will reimburse Executive for the Company’s share of the premiums associated therewith in an amount equal to what the Company pays for the health insurance premiums of other executive level employees
at the Company. The COBRA health continuation period under Section 4980B of the Code shall run concurrently with the period of continued coverage set forth in this Section 5(b)(ii); provided, however, that in the event
Employee obtains other employment that offers group health benefits, such continuation of COBRA coverage by the Company under this Section 5(b)(ii) shall immediately cease. 

  
 7 

 EXECUTION VERSION 

 

 (c) Breach of Restrictive Covenant Agreement. Notwithstanding any other provision of
this Agreement, no payment shall be made or benefit provided pursuant to Section 5(b) following the date Executive first violates the Restrictive Covenant Agreement and, in the event of such a violation, Executive shall
repay to the Company any benefit provided pursuant to Section 5(b) within ninety (90) days of such violation. 

(d) Complete Severance. The provisions of this Section 5 shall supersede in their entirety any severance
payment or benefit obligations to the Executive pursuant to the provisions in any severance plan, policy, program or other arrangement maintained by the Company. 

6. Restrictive Covenant Agreement. The Executive acknowledges that Executive is, concurrently with the execution of this
Agreement, entering into an agreement with the Company containing confidentiality, non-solicitation, non-competition, intellectual property assignment, and other
protective covenants (the “Restrictive Covenant Agreement,” attached hereto as Exhibit A to this Agreement”) and that the Executive shall be bound by the terms and conditions of the Restrictive Covenant Agreement. 

7. Injunctive Relief. The Executive recognizes and acknowledges that a breach of the covenants contained in the
Restrictive Covenant Agreement will cause irreparable damage to the Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate. Accordingly,
the Executive agrees that, in the event of a breach of any of the covenants contained in the Restrictive Covenant Agreement, in addition to any other remedy which may be available at law or in equity, the Company will be entitled to specific
performance and injunctive relief. 
 8. Assignment and Successors. The Company may assign its rights and obligations
under this Agreement to any entity, including any successor to all or substantially all the assets of the Company, by merger or otherwise, and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the Company
and its Affiliates. The Executive may not assign the Executive’s rights or obligations under this Agreement to any individual or entity. This Agreement shall be 

binding upon and inure to the benefit of the Company, the Executive and their respective successors, assigns, personnel and legal representatives, executors,
administrators, heirs, distributees, devisees, and legatees, as applicable. 
 9. Governing Law ;
Venue. This Agreement shall be governed, construed, interpreted and enforced in accordance with the substantive laws of the State of Delaware, without giving effect to any principles of conflicts of law, whether of the State of
Delaware or any other jurisdiction, and where applicable, the laws of the United States, that would result in the application of the laws of any other jurisdiction. Each of the parties hereto agrees that any legal action or proceeding with respect
to this Agreement shall be brought exclusively in the Chancery Court of 

  
 8 

 EXECUTION VERSION 

 

 
New Castle County, Delaware or the federal courts of the United States of America for the District of Delaware, unless the parties to any such action or dispute mutually agree to waive this
provision. By execution and delivery of this Agreement, each of the parties hereto irrevocably consents to service of process out of any of the aforementioned courts in any such action or proceeding by the mailing of copies thereof by registered or
certified mail, postage prepaid, or by recognized express carrier or delivery service, to the applicable party at his, her or its address referred to herein. Each of the parties hereto irrevocably waives any objection which he, she or it may now or
hereafter have to the laying of venue of any of the aforementioned actions or proceedings arising out of or in connection with this Agreement, or any related agreement, certificate or instrument referred to above, brought in the courts referred to
above and hereby further irrevocably waives and agrees, to the fullest extent permitted by applicable law, not to plead or claim in any such court that any such action or proceeding brought in any such court has been brought in any inconvenient
forum. Nothing herein shall affect the right of any party to serve process in any other manner permitted by law. 
 10.
Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.

 11. Notices. Any notice, request, claim, demand, document and other communication hereunder to any party hereto shall
be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by telex, telecopy, or certified or registered mail, postage prepaid, to the following address (or at any other address as any party hereto
shall have specified by notice in writing to the other party hereto): 
 (a) If to the Company: 

GoHealth Holdings, LLC 
 214
West Huron Street 
 Chicago, Illinois 60654 

Attention: Chief Legal Officer or General Counsel 

Copy to: 
 Latham &
Watkins LLP 
 885 Third Avenue 

New York, New York 10022-4802 

Attn: Bradd L. Williamson 

Facsimile: (212) 751-4864 

(b) If to the Executive, at the address set forth on the signature page hereto. 

12. Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original,
but all of which together will constitute one and the same Agreement. 

  
 9 

 EXECUTION VERSION 

 

 13. Entire Agreement. The terms of this Agreement (together with any
other agreements and instruments contemplated hereby or referred to herein, including, without limitation, the Restrictive Covenant Agreement attached hereto as Exhibit A) is intended by the parties hereto to be the final expression of their
agreement with respect to the employment of the Executive by the Company and may not be contradicted by evidence of any prior or contemporaneous agreement (including, without limitation, any other term sheet or offer letter). The parties hereto
further intend that this Agreement shall constitute the complete and exclusive statement of its terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this
Agreement. 
 14. Amendments; Waivers. This Agreement may not be modified, amended, or terminated except by an
instrument in writing, signed by the Executive and a duly authorized officer of GoHealth and approved by the Board, which expressly identifies the amended provision of this Agreement. By an instrument in writing similarly executed and approved by
the Board, the Executive or a duly authorized officer of GoHealth may waive compliance by the other party or parties hereto with any provision of this Agreement that such other party was or is obligated to comply with or perform; provided,
however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure to comply or perform. No failure to exercise and no delay in exercising any right, remedy, or power hereunder shall
preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity. 
 15. No
Inconsistent Actions. The parties hereto shall not voluntarily undertake or fail to undertake any action or course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the
parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement. 

16. Construction. This Agreement shall be deemed drafted equally by both of the parties hereto. Its language shall be
construed as a whole and according to its fair meaning. Any presumption or principle that the language is to be construed against any party hereto shall not apply. The headings in this Agreement are only for convenience and are not intended to
affect construction or interpretation. Any references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the
contrary, (a) the plural includes the singular and the singular includes the plural; (b) “and” and “or” are each used both conjunctively and disjunctively; (c) “any,” “all,” “each,” or
“every” means “any and all,” and “each and every”; (d) ”includes” and “including” are each “without limitation”; (e) “herein,” “hereof,” “hereunder” and
other similar compounds of the word “here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (f) all pronouns and any variations thereof shall be deemed to refer to the
masculine, feminine, neuter, singular or plural as the identity of the Persons referred to may require. 

  
 10 

 EXECUTION VERSION 

 

 17. Enforcement. If any provision of this Agreement is held to be
illegal, invalid or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable
provision had never comprised a portion of this Agreement; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from
this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be
possible and be legal, valid and enforceable. 
 18. Withholding. The Company and its Affiliates shall be entitled to
withhold from any amounts payable under this Agreement, any federal, state, local or foreign withholding or other taxes or charges which the Company or any of its Affiliates is required to withhold. The Company and its Affiliates shall be entitled
to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise. 
 19. Absence of
Conflicts; Executive Acknowledgement; Confidentiality. The Executive hereby represents that from and after the Effective Date the performance of the Executive’s duties hereunder will not breach any other agreement to which the
Executive is a party. The Executive acknowledges that the Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company or any of its
Affiliates other than those contained in writing herein, and has entered into this Agreement freely based on the Executive’s own judgment. The Executive agrees not to disclose the terms or existence of this Agreement to any Person unless the
Company agrees to such disclosure in advance and in writing; provided that the Executive may, without such permission, make such disclosures as are required by applicable law, including disclosures to taxing agencies, and disclose the terms
of this Agreement to the Executive’s attorney(s), accountant(s), tax advisor(s), and other professional service provider(s), and to members of the Executive’s immediate family, as reasonably necessary; provided, further, that
the Executive instructs such Person(s) that the terms of this Agreement are strictly confidential and are not to be revealed to anyone else except as required by applicable law. 

20. Survival. The expiration or termination of the Term shall not impair the rights or obligations of any party hereto
which shall have accrued prior to such expiration or termination (including, without limitation, pursuant to the provisions of the Restrictive Covenant Agreement attached hereto as Exhibit A). 

21. Section 409A. 

(a) General. The parties hereto acknowledge and agree that, to the extent applicable, this Agreement shall be interpreted in accordance
with, and incorporate the terms and conditions required by, Section 409A. Notwithstanding any provision of this Agreement to the contrary, in the event that the Company determines that any amounts payable hereunder will be immediately taxable
to Executive under Section 409A, the Company reserves the right (without any obligation to do so or to indemnify Executive for failure to do so) to (i) adopt such amendments to this Agreement and appropriate policies and procedures,
including amendments and policies with retroactive effect, that the Company determines to be necessary or appropriate to preserve the 

  
 11 

 EXECUTION VERSION 

 

 
intended tax treatment of the benefits provided by this Agreement, to preserve the economic benefits of this Agreement and to avoid less favorable accounting or tax consequences for the Company
and/or (ii) take such other actions as the Company determines to be necessary or appropriate to exempt the amounts payable hereunder from Section 409A or to comply with the requirements of Section 409A and thereby avoid the
application of penalty taxes thereunder. No provision of this Agreement shall be interpreted or construed to transfer any liability for failure to comply with the requirements of Section 409A from Executive or any other individual to the
Company or any of its Affiliates, employees or agents. 
 (b) Separation from Service under Section 409A.
Notwithstanding any provision to the contrary in this Agreement: (i) no amount shall be payable pursuant to Section 5(b) unless the termination of Executive’s employment constitutes a “separation from
service” within the meaning of Section 1.409A-1(h) of the Department of Treasury Regulations; (ii) for purposes of Section 409A, Executive’s right to receive installment payments
pursuant to Section 5(b) shall be treated as a right to receive a series of separate and distinct payments; and (iii) to the extent that any reimbursement of expenses or in-kind
benefits constitutes “deferred compensation” under Section 409A, such reimbursement or benefit shall be provided no later than December 31 of the year following the year in which the expense was incurred. The amount of expenses
reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided in any other year. Notwithstanding any provision to the contrary in this Agreement, if the Executive is deemed at the time of his separation from service to be a “specified
employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the termination benefits to which the Executive is entitled under this Agreement is required in order to avoid a
prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of the Executive’s termination benefits shall not be provided to the Executive prior to the earlier of (x) the expiration of the six-month period measured from the date of the Executive’s “separation from service” with the Company (as such term is defined in the Treasury Regulations issued under Section 409A of the Code)
or (y) the date of the Executive’s death; upon the earlier of such dates, all payments deferred pursuant to this sentence shall be paid in a lump sum to the Executive, and any remaining payments due under the Agreement shall be paid as
otherwise provided herein. 
 (c) Release. Notwithstanding anything to the contrary in this Agreement, to the extent that any payments
of “nonqualified deferred compensation” (within the meaning of Section 409A) due under this Agreement as a result of Executive’s termination of employment are subject to Executive’s execution and delivery of a Release,
(i) the Release shall be reasonable and drafted in good faith (ii) the Company shall deliver the Release to Executive within ten (10) business days following the Date of Termination, and the Company’s failure to deliver a Release
prior to the expiration of such ten (10) business day period shall constitute a waiver of any requirement to execute a Release, (iii) if Executive fails to execute the Release on or prior to the Release Expiration Date (as defined below)
or timely revokes his acceptance of the Release thereafter, Executive shall not be entitled to any payments or benefits otherwise conditioned on the Release, and (iv) in any case where the Date of Termination and the Release Expiration Date
fall in two separate taxable years, any payments required to be made to Executive that are conditioned on the Release and are treated as nonqualified deferred compensation for purposes of Section 409A shall

  
 12 

 EXECUTION VERSION 

 

 
be made in the later taxable year. For purposes of this Section 21(c), “Release Expiration Date” shall mean the date that is twenty-one (21) days following the date upon which the Company timely delivers the Release to Executive, or, in the event that Executive’s termination of employment is “in connection with an exit
incentive or other employment termination program” (as such phrase is defined in the Age Discrimination in Employment Act of 1967), the date that is forty-five (45) days following such delivery date. To the extent that any payments of
nonqualified deferred compensation (within the meaning of Section 409A) due under this Agreement as a result of Executive’s termination of employment are delayed pursuant to Section 5(b) and this
Section 21(c), such amounts shall be paid in a lump sum on the first payroll date following the date that Executive executes and does not revoke the Release (and the applicable revocation period has expired) or, in the case
of any payments subject to Section 21(c)(iv), on the first payroll period to occur in the subsequent taxable year, if later. 

22. Compensation Recovery Policy. The Executive acknowledges and agrees that, to the extent the Company adopts any
clawback or similar policy pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise, and any rules and regulations promulgated thereunder, he shall take all action necessary or appropriate to comply with such policy
(including, without limitation, entering into any further agreements, amendments or policies necessary or appropriate to implement and/or enforce such policy). 

23. Whistleblower Protection and Trade Secrets. Notwithstanding anything to the contrary contained herein, nothing
in this Agreement prohibits Executive from reporting possible violations of federal law or regulation to any United States governmental agency or entity in accordance with the provisions of and rules promulgated under Section 21F of the
Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other whistleblower protection provisions of state or federal law or regulation (including the right to receive an award for information provided to any
such government agencies). Furthermore, in accordance with 18 U.S.C. § 1833, notwithstanding anything to the contrary in this Agreement: (a) Executive shall not be in breach of this Agreement, and shall not be held criminally or civilly
liable under any federal or state trade secret law (i) for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a
suspected violation of law, or (ii) for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (b) if Executive files a lawsuit for
retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney, and may use the trade secret information in the court proceeding, if Executive files any document containing
the trade secret under seal, and does not disclose the trade secret, except pursuant to court order. 
 [Signature pages follow] 

 

  
 13 

 EXECUTION VERSION 

 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date and year
first above written. 
  

			
	GOHEALTH
	
	GOHEALTH, INC.
		
	By:	 	 /s/ Travis J. Matthiesen

	Name:	 	Travis J. Matthiesen
	Title:	 	Chief Financial Officer
	
	PARTNERSHIP
	
	GOHEALTH HOLDINGS, LLC
		
	By:	 	Blizzard Aggregator, LLC
	Its:	 	Managing Member
		
	By:	 	CCP III Cayman GP Ltd.
	Its:	 	Manager
		
	By:	 	 /s/ Jeremy W. Gelber

	Name:	 	Jeremy W. Gelber
	Title:	 	Authorized Signatory

  

 
			
	EXECUTIVE
		
	By:	 	 /s/ Clint Jones

		 	Clint Jones
		
		 	Residence Address:
		
		 	 ####

		 	  

 Exhibit A to Employment Agreement 

RESTRICTIVE COVENANTS AGREEMENT 

THIS RESTRICTIVE COVENANTS AGREEMENT (“Agreement”), dated as of the 7th
day of July, 2020, is made between GoHealth, Inc. (“GoHealth”), GoHealth Holdings, LLC, a Delaware limited liability company (the “Partnership” and, together with GoHealth and any subsidiaries, parent companies or
affiliates of GoHealth or the Partnership, the “Company”), and Clint Jones (the “Executive”), a resident of the State of Illinois. 

RECITALS 
 A. The Company
and the Executive have entered into that certain Employment Agreement dated the date hereof (the “Employment Agreement”). 

B. The Executive possesses extensive knowledge and experience regarding the business of the Company and shall benefit from the Employment
Agreement. 
 AGREEMENT 

NOW, THEREFORE, for good and valuable consideration, which includes the Company’s agreement to employ or continue to employ Executive
under the Employment Agreement and all payments and benefits available to Executive under the Employment Agreement, and in specific consideration for the Company’s agreement to provide the bonus payments set forth in the Employment Agreement,
which Executive acknowledges and agrees is valid and sufficient consideration for the following covenants in this Agreement, the parties hereto agree as follows: 

1. Confidential Information; Non-Disclosure. 

a. Non-Use and Non-Disclosure of Confidential
Information. Executive acknowledges that Executive currently holds and has access to proprietary and confidential information of the Company and its subsidiaries. Executive hereby covenants and agrees that neither Executive nor any of
Executive’s Affiliates (as hereinafter defined) will, at any time, divulge, furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the Company or its subsidiaries, any confidential,
proprietary or secret knowledge or information of the Company that Executive has acquired or shall acquire about the Company or its subsidiaries, whether developed by Executive or by others, including, without limitation, knowledge or information
concerning (i) any trade secrets, (ii) any confidential, proprietary or secret designs, programs, processes, formulae, plans, devices or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the
business of the Company or its subsidiaries, (iii) any customer or supplier lists, (iv) any confidential, proprietary or secret development or research work, (v) any strategic or other business, marketing or sales plans, (vi) any
financial data or plans, or (vii) any other confidential or proprietary information or secret aspects of the business of the Company or its subsidiaries. Executive acknowledges that the above-described knowledge and information constitutes a
unique and valuable asset of the Company and its subsidiaries and represents a substantial investment of time and expense by the 

 
Company and its subsidiaries, and that any disclosure or other use of such knowledge or information other than for the sole benefit of the Company or its subsidiaries would be wrongful and may
cause irreparable harm to the Company and its subsidiaries (“Confidential Information”). Executive shall take reasonable steps to protect the confidentiality of all Confidential Information. The foregoing obligations of
confidentiality shall not apply to any knowledge or information that (i) is now or subsequently becomes generally publicly known, other than as a result of the breach of this Agreement, (ii) is independently made available to Executive in
good faith by a third party who has not violated a confidential relationship with the Company or any of its subsidiaries, or (iii) is required to be disclosed by law or legal process. Executive understands and agrees that his obligations under
this Agreement to maintain the confidentiality of the Company’s and its subsidiaries’ Confidential Information are in addition to any obligations of Executive under applicable statutory or common law. For purposes of this Agreement,
“Affiliate” shall mean any person or entity directly or indirectly controlled by the Executive. 
 b. Company Property. As
between the Company and Executive, all Confidential Information will remain the exclusive property of the Company, including, but not limited to, all financial, commercial, operational, technical or business information or data received, obtained,
or prepared by Executive in connection with Executive’s employment or engagement and concerning the Company’s business, and all copies and abstracts thereof. Upon the termination of Executive’s employment or engagement with the
Company for any reason, Executive will not retain, take, remove, or copy any such property of the Company or any materials containing any Confidential Information whatsoever, and Executive will promptly return all such property and materials to the
Company no later than Executive’s termination date or earlier upon the Company’s request. 
 c. Exceptions; Notice of Legal
Obligation to Disclose. Nothing in this Agreement prohibits Executive from filing a charge with, reporting possible violations of federal law or regulation to, participating in any investigation by, or otherwise cooperating with any governmental
agency or from making other disclosures that are protected under the whistleblower provisions of applicable law or regulation. Further, nothing herein prevents Executive from disclosing Confidential Information if and to the extent required pursuant
to any valid subpoena, court order, or other legal obligation; provided, however, Executive agrees to provide prompt written notice of any such subpoena, court order, or other legal obligation prior to disclosing any Confidential Information (unless
such notice to the Company is prohibited by applicable law), enclosing a copy of the subpoena, court order or other documents describing the legal obligation. In the event that the Company objects to the disclosure of Confidential Information, by
way of a motion to quash or otherwise, Executive agrees to not disclose any Confidential Information while any such objection is pending. 

d. Defend Trade Secrets Act Disclaimer. In compliance with the requirements of the Defend Trade Secrets Act, Executive understands
that: (i) Executive will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney
solely for the purpose of reporting or investigating a suspected violation of law, (ii) Executive will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in a
complaint or other document filed in a lawsuit 

 
or other proceeding, if such filing is made under seal and (iii) if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may
disclose trade secrets to Executive’s attorney and use the trade secret information in the court proceeding if Executive: (a) files any document containing the trade secret under seal; and (b) does not disclose the trade secret,
except pursuant to court order. 
 2. Noncompetition and Nonsolicitation Covenants. 

a. Agreement Not to Compete. Except for Executive’s direct and indirect ownership of the Company, for a period starting as of the
date hereof and ending on such date which is two (2) years after Executive’s Date of Termination (as defined in the Employment Agreement) with the Company or any subsidiary of the Company (the “Restricted Period”),
Executive shall not, directly or indirectly, own, invest in, lend money to, acquire or hold any interest in, render services to, act as agent for, or otherwise engage in any business, in the United States or in any other location in which the
Company is then doing business, that is competitive with any business conducted by or under active consideration by the Company or its subsidiaries at any time during the period that the Executive is an employee, director or direct or indirect
shareholder of the Company or any of its subsidiaries (the “Protected Business”), it being acknowledged by Executive that the Protected Business includes the design, sale, marketing, or distribution of the Company’s and its
subsidiaries’ products and services. Ownership by Executive, as a passive investment, of less than two percent (2%) of the outstanding shares of capital stock of any corporation listed on a national securities exchange or publicly traded in the
over-the-counter market shall not constitute a breach of this Section 2(a). 

b. Agreement Not to Solicit Employees. Executive represents and warrants that Executive has not, directly or indirectly, solicited for
employment for any entity or person (other than for the Company) any current employee, consultant or other independent contractor of the Company. For the Restricted Period, Executive shall not, directly or indirectly, hire, engage, solicit or
attempt to solicit any person who is then an employee, consultant or independent contractor of the Company or any subsidiary of the Company. 

c. Agreement Not to Solicit Others. Executive represents and warrants that Executive has not, directly or indirectly, solicited any
customer, supplier, distributor or other business contact referred to below for the purposes set forth below (other than on behalf of the Company). For the Restricted Period, Executive shall not, directly or indirectly, in any manner or capacity,
including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, (x) solicit or attempt to solicit any person or entity who was a customer of
the Company during the last twelve (12) months immediately preceding the date hereof or is a customer of the Company or any subsidiary of the Company during the Restricted Period, for the purposes of selling, marketing or distributing products
or services similar to the products or services designed, sold, marketed or distributed by the Company or any of its subsidiaries, and (y) solicit, request, advise or induce any supplier, distributor or other business contact of the Company or
any subsidiary to cancel, curtail or otherwise adversely change its relationship with the Company or its subsidiaries as it relates, directly or indirectly, to the Protected Business. 

 d. Acknowledgment. Executive hereby acknowledges that the provisions of this
Section 2 are reasonable and necessary to protect the legitimate interests of the Company and that any violation of this Section 2 by Executive may cause substantial and irreparable harm to the
Company to such an extent that monetary damages alone would be an inadequate remedy therefor. 
 e. Assistance is Prohibited.
Executive further agrees that Executive will not, directly or indirectly, assist or encourage any other person in carrying out, directly or indirectly, any activity that would be prohibited by the above provisions of this
Section 2 if such activity were carried out by Executive, directly or indirectly, or induce any employee, or former employee of the Company to carry out, directly or indirectly, any such activity. 

f. Blue Pencil Doctrine. If the duration of, the scope of or any business activity covered by any provision of this
Section 2 is in excess of what is determined to be valid and enforceable under applicable law, such provision shall be construed to cover only that duration, scope or activity that is determined to be valid and enforceable.
Executive hereby acknowledges that this Section 2 shall be given the construction which renders its provisions valid and enforceable to the maximum extent, snot exceeding its express terms, possible under applicable law.

 3. Non-Disparagement. The Executive agrees not to disparage the Company, any of its
products, services, or practices, or any of its directors, officers, agents, representatives, partners, members, equity holders, or affiliates, either orally or in writing, at any time; provided, that the Executive may confer in confidence
with the Executive’s legal representatives and make truthful statements as required by law. 
 4. Ownership of Inventions. 

a. Inventions. Subject to the limitations in Section 4(c) below, the Company will own all rights, title and
interest in and to (i) any invention, innovation, manufacturing process, trade secret, design, idea or improvement related, directly or indirectly, to the Company’s business, or any part thereof, and (ii) all copyrights, patents,
trademarks and trade names which Executive develops or creates, in whole or in part in the course of Executive’s employment or engagement with the Company (referred to as “Inventions”). Subject to the limitations in
Section 4(c) below, Executive will, and hereby does, assign to the Company, without requirement of further writing and without royalty or any other further consideration, my entire right, title and interest throughout the
world in and to all Inventions created, conceived, made, developed, and/or reduced to practice by Executive in the course of Executive’s employment or engagement with the Company and all intellectual property rights therein. Executive will
promptly tell the Company about and give the Company all information relating to any such Inventions. Executive acknowledges that all original works of authorship which are made by Executive (solely or jointly with others) within the scope of
Executive’s employment or engagement with the Company and which are eligible for copyright protection are “works made for hire” as that term is defined in the United States Copyright Act (17 U.S.C., Section 101). Executive hereby
waives, and agrees to waive, any moral rights Executive may have in any copyrightable work Executive creates or has created on behalf of the Company. Executive will make and maintain adequate and current written records of all Inventions covered by
this Section 4(a). These records may be in the form of notes, sketches, drawings, flow charts, electronic data or recordings, notebooks and any other format. These records shall be and remain the property of the Company at
all times and shall be made available to the Company at all times. 

 b. Cooperation. Executive will cooperate with the Company in obtaining, maintaining
and enforcing copyright, patent, trademark or other relevant protections for Inventions covered by Section 4(a), including executing such documents as the Company may request as necessary for such protection. 

c. Executive Inventions. Executive acknowledges that the Company will not own, and the assignment of Inventions set forth in
Section 4(a) above does not apply to, Inventions for which no equipment, supplies, facility, or trade secret information of Company were used and which was developed entirely on Executive’s own time (“Executive
Inventions”), unless (i) the Invention relates (a) to the Company’s business or (b) to the Company’s actual or demonstrably anticipated research or development, or (ii) the Invention results from any work
performed by Executive for the Company. If Executive believes an Invention qualifies as an Executive Invention, Executive will provide the Company at the time of creation written evidence to substantiate such belief. If Executive incorporates any
Executive Inventions or portions thereof into any Inventions created or developed for the Company, Executive hereby grants the Company a perpetual, irrevocable, royalty-free, transferable license to copy, modify, prepare derivative works of, use,
perform, and display such Executive Invention solely in connection with the Invention. 
 5. Enforcement. Executive hereby
specifically acknowledges and agrees that the scope of the restrictions set forth in this Agreement is reasonable and necessary to ensure that the Company receives the value of the Employment Agreement and that violation of this Agreement will harm
the Company to such an extent that monetary damages alone would be an inadequate remedy. Therefore, in the event of any violation by Executive or any Affiliate: 

a. the Company (in addition to all other remedies the Company may have) shall be entitled to a temporary restraining order, injunction and
other equitable relief (without posting any bond or other security) restraining the violator from committing or continuing such violation, 

b. in the case of any violation of Section 2 hereof, as determined by a final judgment of court of competent
jurisdiction, the duration of the non-compete period referred to therein shall be extended beyond its then-scheduled termination date for a period equal to the duration of the violation, and 

c. in the event that the Company must enforce this Agreement pursuant to this Section 5, the Company shall be
entitled to recover from Executive its reasonable costs associated therewith, including all reasonable attorneys’ and court fees. 
 6.
Use of Name. Neither Executive nor any Affiliate shall use the name “GoHealth,” any variants thereof, or any confusingly similar name, in any business (other than the Company) in which any of them is associated as shareholder,
investor, lender, partner, co-venturer, co-marketer, sole proprietor, director, officer, employee, agent, consultant, independent contractor or in any other capacity. 

 7. No Violation of Other Agreements. Executive hereby represents and agrees that
neither (a) Executive’s entering into this Agreement nor (b) Executive’s carrying out the provisions of this Agreement, will violate any other agreement (oral, written or other) to which Executive is a party or by which Executive
is bound. 
 8. At-Will Employment; No Contract of Employment. Nothing herein shall be deemed
to create a contract of employment for any term. Executive acknowledges and agrees that Executive’s employment with the Company is and shall remain at all times at will, unless otherwise specified by the Employment Agreement. 

9. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of Executive, the Company and their respective
heirs, personal representatives, successors and assigns (including without limitation any assignee of substantially all of the assets of the Company); provided, however, that this Agreement may not be assigned by Executive. 

10. Complete Agreement. This Agreement contains the complete agreement between the parties hereto with respect to the matters covered
herein, and supersedes all prior agreements and understandings between the parties hereto with respect to such matters. This Agreement may be amended, terminated or superseded only by an agreement in writing executed by both parties hereto. 

11. Partial Invalidity. If any covenant or other provision of this Agreement is deemed invalid, illegal or incapable of being enforced
by reason of any rule of law or of any public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect and no covenant or provision shall be deemed dependent upon any other covenant or
provision unless so expressed herein. 
 12. No Waiver. No term or condition of this Agreement shall be deemed to have been waived,
nor shall there be any estoppel to enforce any provision of this Agreement, except by a statement in writing signed by the party against whom enforcement of the waiver or estoppel is sought. Any written waiver shall not be deemed a continuing waiver
unless specifically stated, shall operate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived. 

13. Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed an original but both of which shall
constitute but one instrument. 
 14. Headings. The headings contained in this Agreement are for reference purposes only and shall not
be deemed to be a part of this Agreement or to affect the meaning or interpretation of this Agreement. 
 15. Notices. All notices,
requests, demands and other communications provided for in this Agreement shall be in writing delivered personally or sent by registered or certified mail, postage prepaid, as follows: 

					
		 	If to the Company:	  	GoHealth Holdings, LLC
	        	 		  	214 West Huron Street
		 		  	Chicago, IL 60654
			
		 	with a copy to:	  	Centerbridge Partners, L.P.
		 		  	375 Park Ave., 11th Floor
		 		  	New York, NY 10152
			
		 	If to Executive:	  	To the address set forth on the Executive’s signature page of the Employment Agreement
			
		 	with a copy to:	  	Croke Fairchild Morgan & Beres
		 		  	180 N. LaSalle St., Ste. 2750
		 		  	Chicago, IL 60601
		 		  	Attn: Patrick E. Croke

 16. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the
State of Delaware, without giving effect to any choice or conflict of law provision or rule, whether of the State of Delaware or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Delaware.

 17. Action of Affiliates. Executive shall cause his Affiliates not to take any action that is prohibited to be taken by such
Affiliates under the terms of this Agreement. 
 [Signature pages follow] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first above written. 
  

			
		 	GOHEALTH, INC.
		
	By:	 	 /s/ Travis J. Matthiesen

	Name:	 	Travis J. Matthiesen
	Title:	 	Chief Financial Officer
		
		 	GOHEALTH HOLDINGS, LLC
		
	By:	 	Blizzard Aggregator, LLC
	Its:	 	Managing Member
		
	By:	 	CCP III Cayman GP Ltd.
	Its:	 	Manager
		
	By:	 	 /s/ Jeremy W. Gelber

	Name:	 	Jeremy W. Gelber
	Title:	 	Authorized Signatory
		
		 	EXECUTIVE
		
		 	 /s/ Clint Jones

		 	Clint Jones

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]